ArticleTravel medicine and infectious disease
Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral hospital in Marseille, France, - January 31st to March 1st, 2020: A respiratory virus snapshot.
Article in Travel medicine and infectious disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04370262 (A Multi-site, Randomized, Double-Blind, Comparative Trial of the Safety and Efficacy of Standard of Care), which is not on this map. Cited by 71 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Multi-site, Randomized, Double-Blind, Comparative Trial of the Safety and Efficacy of Standard of Care (SOC) Plus Famotidine vs SOC Plus Placebo for the Treatment of COVID-19 in Hospitalized Adults
Who cites it
71 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- A meta-analysis of accuracy and sensitivity of chest CT and RT-PCR in COVID-19 diagnosis.Scientific reports · 2020Pooled it
- Molecular diagnosis of COVID-19 in different biologic matrix, their diagnostic validity and clinical relevance: A systematic review.Life sciences · 2020Pooled it
- Clinical Characteristics and Diagnostic Challenges of COVID-19: An Update From the Global Perspective.Frontiers in public health · 2020Pooled it
- RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.International journal of antimicrobial agents · 2020Trial
- Microscopic observations of SARS-CoV-2 like particles in different oral samples.European journal of oral sciences · 2022Article
- Evidence of antibodies against SARS-CoV-2 in wild mustelids from Brittany (France).Transboundary and emerging diseases · 2022Article
- Article
- First evidence of human-to-dog transmission of SARS-CoV-2 B.1.160 variant in France.Transboundary and emerging diseases · 2022Article
- Control of common viral epidemics but not of SARS-CoV-2 through the application of hygiene and distancing measures.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2022Article
- Antiviral Activity of Repurposing Ivermectin against a Panel of 30 Clinical SARS-CoV-2 Strains Belonging to 14 Variants.Pharmaceuticals (Basel, Switzerland) · 2022Article
- Value and prognostic impact of a deep learning segmentation model of COVID-19 lung lesions on low-dose chest CT.Research in diagnostic and interventional imaging · 2022Article
- Exploratory Study on Application of MALDI-TOF-MS to Detect SARS-CoV-2 Infection in Human Saliva.Journal of clinical medicine · 2022Article
- Outcomes of 2111 COVID-19 Hospitalized Patients Treated with Hydroxychloroquine/Azithromycin and Other Regimens in Marseille, France, 2020: A Monocentric Retrospective Analysis.Therapeutics and clinical risk management · 2022Article
- COVID-19: National Pandemic Management Strategies and their Efficacies and Impacts on the Number of Secondary Cases and Prognosis: A Systematic Review.International journal of preventive medicine · 2022Review
- Long-Term Persistence of Olfactory and Gustatory Disorders in COVID-19 Patients.Frontiers in medicine · 2022Article
- Article
- Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis.Cell death and differentiation · 2021Article
- Clinical outcomes in patients infected with different SARS-CoV-2 variants at one hospital during three phases of the COVID-19 epidemic in Marseille, France.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2021Article
- Clinical outcomes in COVID-19 patients infected with different SARS-CoV-2 variants in Marseille, France.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2021Article
- Mouth Washing Impaired SARS-CoV-2 Detection in Saliva.Diagnostics (Basel, Switzerland) · 2021Article
11 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
21 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRapid virological diagnosis is needed to limit the length of isolation for suspected COVID-19 cases.
methodWe managed the first 280 patients suspected to have COVID-19 through a rapid care circuit and virological diagnosis in our infectious disease reference hospital in Marseille, France. Rapid viral detection was performed on sputum and nasopharyngeal samples.
resultsOver our study period, no SARS-CoV-2 was detected. Results were obtained within approximately 3 h of the arrival of patient samples at the laboratory. Other viral infections were identified in 49% of the patients, with most common pathogens being influenza A and B viruses, rhinovirus, metapneumovirus and common coronaviruses, notably HKU1 and NL63.
conclusionEarly recognition of COVID-19 is critical to isolate confirmed cases and prevent further transmission. Early rule-out of COVID-19 allows public health containment measures to be adjusted by reducing the time spent in isolation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.